Neglected Disease（忽略病害）市場的市場機會：1∼5卷

Neglected Disease（忽略病害）市場的市場機會：1∼5卷 是由出版商Insight Pharma Reports在2006年02月所出版的。 這份英文市場調查報告書價格從美金2100起跳。

簡介

目錄

Sleeper diseases comprise a broad spectrum of increasingly recognized conditions with various degrees of neuropsychiatric involvement. Many of these conditions are now clearly defined, earning them increasing acceptance as real disorders that can and should be addressed by pharmacotherapy.

Several of these emerging sleeper diseases share key properties that make them highly interesting for the pharmaceutical industry:

• They are well defined and "real" beyond any reasonable doubt, although their etiology might be unknown or scientists' understanding of them might be highly incomplete.
• They affect a considerable number of otherwise healthy individuals in ways that significantly compromise their quality of life, social functioning, and professional accomplishments.
• They respond to treatment with currently available medications (or at least some of their constituent aspects do to a limited degree), and novel drugs (frequently based on genetic insights that reveal possible targets) are being investigated on the basis of scientifically defendable working hypotheses.

In this report, five syndromes the author believes will develop into significant pharmaceutical markets through 2015 have been evaluated.

Table of Contents

• Symptoms, Diagnosis, and Epidemiology
• Etiology
• Inconclusive Results of Genetic Investigations
• Current Drug Treatments and Trials Involving Drugs Approved for Other Indications
  • Anticonvulsants
  • Selective Serotonin Reuptake Inhibitors
  • Atypical Antipsychotics
  • Cholinesterase Inhibitors
  • Antioxidants and Antiexcitatory Drugs
• Potential New Drugs for Autism and Autistic Spectrum Disorders
  • Specific Challenges for Drug Development in Autism
  • Secretin: A Failed Hope
  • CureMark's Digestive Enzymes
  • Oralgam: An Oral Immunoglobulin with Presumed Intestinal Action
  • RG-2077: Another Potential Immunotherapy
  • SRX-251
  • Other Approaches Described in the Patent Literature
• The Autism Drug Therapy Market to 2015
  • A Target Population with a Largely Unpredictable Development
  • Sales Development To Be Driven by New Drugs

References

Index

FIGURES

• Figure 1. Key Symptoms of Autism
• Figure 2. Incidence of U.S. Autism Cases, 1992 to 2003

TABLES

• Table 1. Drugs Approved for Other Indications That Are Used to Manage or Are in Clinical Trials for Autism
• Table 2. Potential New Drugs for Use in Autism

相關商品

神經疾病相關市場調查報告書

疼痛治療藥市場的發展：侵害受容性及神經性疼痛治療藥的開發
Evolution in the Pain Therapy Drugs Market: Nociceptive and Neuropathic Drug Development
價格 : US $ 2265
出版日期 : 2012年01月

神經保護：醫療藥品・市場・企業
Neuroprotection - Drugs, Markets and Companies
價格 : US $ 5000
出版日期 : 2012年01月

阿茲海默症：新藥・市場・企業
Alzheimer disease - new drugs, markets and companies
價格 : US $ 3500
出版日期 : 2012年01月

Insight Pharma Reports發行的製藥相關市場調查報告書

PI3k/Akt/mTOR途徑:開發平台分析

The PI3K/Akt/mTOR Pathway: A Pipeline Analysis - Overview

價格 : US $ 2495

出版日期 : 2011年11月

預防和治療性疫苗之新趨勢：概要

New Trends in Preventive and Therapeutic Vaccines - Overview

價格 : US $ 2495

出版日期 : 2011年10月

激酶標靶治療：開發產品線、挑戰及機會

Kinase-Targeted Therapeutics: Development Pipelines, Challenges, and Opportunities

價格 : US $ 3195

出版日期 : 2011年08月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!